-
-
Human metapneumovirus was the likely cause of 12% of all lower respiratory tract illnesses among a population of 2009 children studied from 1976 to 2001 presenting with acute respiratory symptoms. Clinical manifestations of metapneumovirus infection were bronchiolitis (59%), croup (18%), pneumonia (8%), and exacerbation of asthma (14%).
-
This summary of selected abstracts from 3 meetings is published in multiple parts. The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) met in Chicago September 14-17, 2003. The Infectious Disease Society of America (IDSA) met in San Diego October 9-12, 2003. The American Society of Tropical Medicine and Hygiene met in Philadelphia December 3-7, 2003.
-
Includes the following Articles: Improved Blood Donor Screening for WNV, Azithromycin Failure as Prophylaxis or Treatment of Syphilis, United Kingdom Cracks Down on Potential Blood Donors and Human and Feline Sporotrichosis in Rio.
-
-
-
When it comes to treating lipids in patients with heart disease, the mantra may be, The lower the LDL, the better. Data from the multicenter Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial indicate that aggressive reduction of atherogenic lipoproteins prevents progression of disease.
-
The use of serum procalcitonin helps to differentiate bacterial from viral lower respiratory infections and may reduce the use of unnecessary antibiotics.
-
The common and increasing practice of opioid treatment for chronic pain is reviewed. Randomized trials support this therapy, however the risk benefit decision is complicated by new evidence of hazards making this practice more difficult.
-
Long-term treatment with aspirin is associated with a progressive diminution in platelet sensitivity to the drug.